Vinblastinesulphate (CAS 143-67-9) is a white or light yellow amorphous power, which is easily soluble in water. Vinblastine belongs to the group of cancer-fighting medications known as antineoplastics. Vinblastine is used alone or in combination with other antineoplastic medications to treat many different types of cancer including Hodgkin's disease, non-Hodgkin's lymphoma (cancer of the lymph cells), Kaposi's sarcoma, breast cancer, and testicular cancer. It kills cancer cells by interfering with the genetic material DNA, which is necessary for their growth and reproduction.
The global Vinblastinesulphate market is projected to grow from US$ 22 million in 2024 to US$ 24 million by 2030, at a Compound Annual Growth Rate (CAGR) of 1.1% during the forecast period.
Global Vinblastinesulphate (CAS 143-67-9) key players include Guangzhou Hanfang Pharmaceutical, Hainan Vinca Biological Medicine Technology, Guangzhou Person Pharmaceutical, Hainan Yueyang Biotechnology, etc. Global top four manufacturers hold a share about 60%.
China is the largest market, with a share about 40%, followed by Europe and USA, have a share over 40 percent.
In terms of product, 97-98% Vinblastinesulphate is the largest segment, with a share about 60%. And in terms of application, the largest application is Lymphoma, followed by Lung Cancer, Breast & Ovarian Cancer, Leukemia, ect.
In terms of production side, this report researches the Vinblastinesulphate production, growth rate, market share by manufacturers and by region (region level and country level), from 2019 to 2024, and forecast to 2030.
In terms of consumption side, this report focuses on the sales of Vinblastinesulphate by region (region level and country level), by company, by Type and by Application. from 2019 to 2024 and forecast to 2030.
Report Covers:
This report presents an overview of global market for Vinblastinesulphate, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2024, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Vinblastinesulphate, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Vinblastinesulphate, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Vinblastinesulphate sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Vinblastinesulphate market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Vinblastinesulphate sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Guangzhou Hanfang Pharmaceutical
Hainan Vinca Biological Medicine Technology
Guangzhou Person Pharmaceutical
Hainan Yueyang Biotechnology
Hubei Honch Pharmaceutical
Fine Chemicals Corporation
Hengtengfu Biological Products
Vinkem
Segment by Type
>98% Vinblastinesulphate
97-98% Vinblastinesulphate
Other
Segment by Application
Lymphoma
Lung Cancer
Breast & Ovarian Cancer
Leukemia
Other
Production by Region
South Africa
India
China
Sales by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Vinblastinesulphate production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Vinblastinesulphate in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Vinblastinesulphate manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: China by Type, and by Application, sales, and revenue for each segment.
Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 11: Middle East, Africa, Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Vinblastinesulphate sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Vinblastinesulphate Product Introduction
1.2 Market by Type
1.2.1 Global Vinblastinesulphate Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 >98% Vinblastinesulphate
1.2.3 97-98% Vinblastinesulphate
1.2.4 Other
1.3 Market by Application
1.3.1 Global Vinblastinesulphate Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Lymphoma
1.3.3 Lung Cancer
1.3.4 Breast & Ovarian Cancer
1.3.5 Leukemia
1.3.6 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Vinblastinesulphate Production
2.1 Global Vinblastinesulphate Production Capacity (2019-2030)
2.2 Global Vinblastinesulphate Production by Region: 2019 VS 2023 VS 2030
2.3 Global Vinblastinesulphate Production by Region
2.3.1 Global Vinblastinesulphate Historic Production by Region (2019-2024)
2.3.2 Global Vinblastinesulphate Forecasted Production by Region (2025-2030)
2.3.3 Global Vinblastinesulphate Production Market Share by Region (2019-2030)
2.4 South Africa
2.5 India
2.6 China
3 Executive Summary
3.1 Global Vinblastinesulphate Revenue Estimates and Forecasts 2019-2030
3.2 Global Vinblastinesulphate Revenue by Region
3.2.1 Global Vinblastinesulphate Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Vinblastinesulphate Revenue by Region (2019-2024)
3.2.3 Global Vinblastinesulphate Revenue by Region (2025-2030)
3.2.4 Global Vinblastinesulphate Revenue Market Share by Region (2019-2030)
3.3 Global Vinblastinesulphate Sales Estimates and Forecasts 2019-2030
3.4 Global Vinblastinesulphate Sales by Region
3.4.1 Global Vinblastinesulphate Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Vinblastinesulphate Sales by Region (2019-2024)
3.4.3 Global Vinblastinesulphate Sales by Region (2025-2030)
3.4.4 Global Vinblastinesulphate Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (excluding China)
3.9 Middle East, Africa and Latin America
4 Competition by Manufactures
4.1 Global Vinblastinesulphate Sales by Manufacturers
4.1.1 Global Vinblastinesulphate Sales by Manufacturers (2019-2024)
4.1.2 Global Vinblastinesulphate Sales Market Share by Manufacturers (2019-2024)
4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Vinblastinesulphate in 2023
4.2 Global Vinblastinesulphate Revenue by Manufacturers
4.2.1 Global Vinblastinesulphate Revenue by Manufacturers (2019-2024)
4.2.2 Global Vinblastinesulphate Revenue Market Share by Manufacturers (2019-2024)
4.2.3 Global Top 10 and Top 5 Companies by Vinblastinesulphate Revenue in 2023
4.3 Global Vinblastinesulphate Sales Price by Manufacturers
4.4 Global Key Players of Vinblastinesulphate, Industry Ranking, 2022 VS 2023 VS 2024
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Vinblastinesulphate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Key Manufacturers of Vinblastinesulphate, Manufacturing Base Distribution and Headquarters
4.7 Global Key Manufacturers of Vinblastinesulphate, Product Offered and Application
4.8 Global Key Manufacturers of Vinblastinesulphate, Date of Enter into This Industry
4.9 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Vinblastinesulphate Sales by Type
5.1.1 Global Vinblastinesulphate Historical Sales by Type (2019-2024)
5.1.2 Global Vinblastinesulphate Forecasted Sales by Type (2025-2030)
5.1.3 Global Vinblastinesulphate Sales Market Share by Type (2019-2030)
5.2 Global Vinblastinesulphate Revenue by Type
5.2.1 Global Vinblastinesulphate Historical Revenue by Type (2019-2024)
5.2.2 Global Vinblastinesulphate Forecasted Revenue by Type (2025-2030)
5.2.3 Global Vinblastinesulphate Revenue Market Share by Type (2019-2030)
5.3 Global Vinblastinesulphate Price by Type
5.3.1 Global Vinblastinesulphate Price by Type (2019-2024)
5.3.2 Global Vinblastinesulphate Price Forecast by Type (2025-2030)
6 Market Size by Application
6.1 Global Vinblastinesulphate Sales by Application
6.1.1 Global Vinblastinesulphate Historical Sales by Application (2019-2024)
6.1.2 Global Vinblastinesulphate Forecasted Sales by Application (2025-2030)
6.1.3 Global Vinblastinesulphate Sales Market Share by Application (2019-2030)
6.2 Global Vinblastinesulphate Revenue by Application
6.2.1 Global Vinblastinesulphate Historical Revenue by Application (2019-2024)
6.2.2 Global Vinblastinesulphate Forecasted Revenue by Application (2025-2030)
6.2.3 Global Vinblastinesulphate Revenue Market Share by Application (2019-2030)
6.3 Global Vinblastinesulphate Price by Application
6.3.1 Global Vinblastinesulphate Price by Application (2019-2024)
6.3.2 Global Vinblastinesulphate Price Forecast by Application (2025-2030)
7 US & Canada
7.1 US & Canada Vinblastinesulphate Market Size by Type
7.1.1 US & Canada Vinblastinesulphate Sales by Type (2019-2030)
7.1.2 US & Canada Vinblastinesulphate Revenue by Type (2019-2030)
7.2 US & Canada Vinblastinesulphate Market Size by Application
7.2.1 US & Canada Vinblastinesulphate Sales by Application (2019-2030)
7.2.2 US & Canada Vinblastinesulphate Revenue by Application (2019-2030)
7.3 US & Canada Vinblastinesulphate Sales by Country
7.3.1 US & Canada Vinblastinesulphate Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 US & Canada Vinblastinesulphate Sales by Country (2019-2030)
7.3.3 US & Canada Vinblastinesulphate Revenue by Country (2019-2030)
7.3.4 U.S.
7.3.5 Canada
8 Europe
8.1 Europe Vinblastinesulphate Market Size by Type
8.1.1 Europe Vinblastinesulphate Sales by Type (2019-2030)
8.1.2 Europe Vinblastinesulphate Revenue by Type (2019-2030)
8.2 Europe Vinblastinesulphate Market Size by Application
8.2.1 Europe Vinblastinesulphate Sales by Application (2019-2030)
8.2.2 Europe Vinblastinesulphate Revenue by Application (2019-2030)
8.3 Europe Vinblastinesulphate Sales by Country
8.3.1 Europe Vinblastinesulphate Revenue by Country: 2019 VS 2023 VS 2030
8.3.2 Europe Vinblastinesulphate Sales by Country (2019-2030)
8.3.3 Europe Vinblastinesulphate Revenue by Country (2019-2030)
8.3.4 Germany
8.3.5 France
8.3.6 U.K.
8.3.7 Italy
8.3.8 Russia
9 China
9.1 China Vinblastinesulphate Market Size by Type
9.1.1 China Vinblastinesulphate Sales by Type (2019-2030)
9.1.2 China Vinblastinesulphate Revenue by Type (2019-2030)
9.2 China Vinblastinesulphate Market Size by Application
9.2.1 China Vinblastinesulphate Sales by Application (2019-2030)
9.2.2 China Vinblastinesulphate Revenue by Application (2019-2030)
10 Asia (excluding China)
10.1 Asia Vinblastinesulphate Market Size by Type
10.1.1 Asia Vinblastinesulphate Sales by Type (2019-2030)
10.1.2 Asia Vinblastinesulphate Revenue by Type (2019-2030)
10.2 Asia Vinblastinesulphate Market Size by Application
10.2.1 Asia Vinblastinesulphate Sales by Application (2019-2030)
10.2.2 Asia Vinblastinesulphate Revenue by Application (2019-2030)
10.3 Asia Vinblastinesulphate Sales by Region
10.3.1 Asia Vinblastinesulphate Revenue by Region: 2019 VS 2023 VS 2030
10.3.2 Asia Vinblastinesulphate Revenue by Region (2019-2030)
10.3.3 Asia Vinblastinesulphate Sales by Region (2019-2030)
10.3.4 Japan
10.3.5 South Korea
10.3.6 China Taiwan
10.3.7 Southeast Asia
10.3.8 India
11 Middle East, Africa and Latin America
11.1 Middle East, Africa and Latin America Vinblastinesulphate Market Size by Type
11.1.1 Middle East, Africa and Latin America Vinblastinesulphate Sales by Type (2019-2030)
11.1.2 Middle East, Africa and Latin America Vinblastinesulphate Revenue by Type (2019-2030)
11.2 Middle East, Africa and Latin America Vinblastinesulphate Market Size by Application
11.2.1 Middle East, Africa and Latin America Vinblastinesulphate Sales by Application (2019-2030)
11.2.2 Middle East, Africa and Latin America Vinblastinesulphate Revenue by Application (2019-2030)
11.3 Middle East, Africa and Latin America Vinblastinesulphate Sales by Country
11.3.1 Middle East, Africa and Latin America Vinblastinesulphate Revenue by Country: 2019 VS 2023 VS 2030
11.3.2 Middle East, Africa and Latin America Vinblastinesulphate Revenue by Country (2019-2030)
11.3.3 Middle East, Africa and Latin America Vinblastinesulphate Sales by Country (2019-2030)
11.3.4 Brazil
11.3.5 Mexico
11.3.6 Turkey
11.3.7 Israel
11.3.8 GCC Countries
12 Corporate Profiles
12.1 Guangzhou Hanfang Pharmaceutical
12.1.1 Guangzhou Hanfang Pharmaceutical Company Information
12.1.2 Guangzhou Hanfang Pharmaceutical Overview
12.1.3 Guangzhou Hanfang Pharmaceutical Vinblastinesulphate Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.1.4 Guangzhou Hanfang Pharmaceutical Vinblastinesulphate Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Guangzhou Hanfang Pharmaceutical Recent Developments
12.2 Hainan Vinca Biological Medicine Technology
12.2.1 Hainan Vinca Biological Medicine Technology Company Information
12.2.2 Hainan Vinca Biological Medicine Technology Overview
12.2.3 Hainan Vinca Biological Medicine Technology Vinblastinesulphate Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.2.4 Hainan Vinca Biological Medicine Technology Vinblastinesulphate Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Hainan Vinca Biological Medicine Technology Recent Developments
12.3 Guangzhou Person Pharmaceutical
12.3.1 Guangzhou Person Pharmaceutical Company Information
12.3.2 Guangzhou Person Pharmaceutical Overview
12.3.3 Guangzhou Person Pharmaceutical Vinblastinesulphate Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.3.4 Guangzhou Person Pharmaceutical Vinblastinesulphate Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Guangzhou Person Pharmaceutical Recent Developments
12.4 Hainan Yueyang Biotechnology
12.4.1 Hainan Yueyang Biotechnology Company Information
12.4.2 Hainan Yueyang Biotechnology Overview
12.4.3 Hainan Yueyang Biotechnology Vinblastinesulphate Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.4.4 Hainan Yueyang Biotechnology Vinblastinesulphate Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Hainan Yueyang Biotechnology Recent Developments
12.5 Hubei Honch Pharmaceutical
12.5.1 Hubei Honch Pharmaceutical Company Information
12.5.2 Hubei Honch Pharmaceutical Overview
12.5.3 Hubei Honch Pharmaceutical Vinblastinesulphate Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.5.4 Hubei Honch Pharmaceutical Vinblastinesulphate Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Hubei Honch Pharmaceutical Recent Developments
12.6 Fine Chemicals Corporation
12.6.1 Fine Chemicals Corporation Company Information
12.6.2 Fine Chemicals Corporation Overview
12.6.3 Fine Chemicals Corporation Vinblastinesulphate Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.6.4 Fine Chemicals Corporation Vinblastinesulphate Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Fine Chemicals Corporation Recent Developments
12.7 Hengtengfu Biological Products
12.7.1 Hengtengfu Biological Products Company Information
12.7.2 Hengtengfu Biological Products Overview
12.7.3 Hengtengfu Biological Products Vinblastinesulphate Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.7.4 Hengtengfu Biological Products Vinblastinesulphate Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Hengtengfu Biological Products Recent Developments
12.8 Vinkem
12.8.1 Vinkem Company Information
12.8.2 Vinkem Overview
12.8.3 Vinkem Vinblastinesulphate Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.8.4 Vinkem Vinblastinesulphate Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Vinkem Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Vinblastinesulphate Industry Chain Analysis
13.2 Vinblastinesulphate Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Vinblastinesulphate Production Mode & Process
13.4 Vinblastinesulphate Sales and Marketing
13.4.1 Vinblastinesulphate Sales Channels
13.4.2 Vinblastinesulphate Distributors
13.5 Vinblastinesulphate Customers
14 Vinblastinesulphate Market Dynamics
14.1 Vinblastinesulphate Industry Trends
14.2 Vinblastinesulphate Market Drivers
14.3 Vinblastinesulphate Market Challenges
14.4 Vinblastinesulphate Market Restraints
15 Key Finding in The Global Vinblastinesulphate Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Guangzhou Hanfang Pharmaceutical
Hainan Vinca Biological Medicine Technology
Guangzhou Person Pharmaceutical
Hainan Yueyang Biotechnology
Hubei Honch Pharmaceutical
Fine Chemicals Corporation
Hengtengfu Biological Products
Vinkem
听
听
*If Applicable.
